A detailed history of Cetera Investment Advisers transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 13,877 shares of ABCL stock, worth $40,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,877
Holding current value
$40,520
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.39 - $3.49 $33,166 - $48,430
13,877 New
13,877 $35,000
Q1 2024

May 24, 2024

BUY
$4.29 - $5.97 $98,142 - $136,575
22,877 New
22,877 $103,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $833M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.